↓ Skip to main content

PLOS

Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice

Overview of attention for article published in PLOS ONE, February 2012
Altmetric Badge

Mentioned by

patent
10 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
55 Mendeley
Title
Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice
Published in
PLOS ONE, February 2012
DOI 10.1371/journal.pone.0031967
Pubmed ID
Authors

Lucie Mondoulet, Vincent Dioszeghy, Thibaut Larcher, Mélanie Ligouis, Véronique Dhelft, Emilie Puteaux, Yan Cherel, Franck Letourneur, Christophe Dupont, Pierre-Henri Benhamou

Abstract

Food allergy may affect the gastrointestinal tract and eosinophilia is often associated with allergic gastrointestinal disorders. Allergy to peanuts is a life-threatening condition and effective and safe treatments still need to be developed. The present study aimed to evaluate the effects of sustained oral exposure to peanuts on the esophageal and jejunal mucosa in sensitized mice. We also evaluated the effects of desensitization with epicutaneous immunotherapy (EPIT) on these processes.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 54 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 20%
Researcher 10 18%
Other 7 13%
Student > Ph. D. Student 7 13%
Student > Master 6 11%
Other 7 13%
Unknown 7 13%
Readers by discipline Count As %
Medicine and Dentistry 12 22%
Agricultural and Biological Sciences 12 22%
Immunology and Microbiology 11 20%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Biochemistry, Genetics and Molecular Biology 2 4%
Other 6 11%
Unknown 8 15%